Besides RT-QuIC, two other biomarkers can be considered specific for prion diseases: malate dehydrogenase 1 with a sensitivity and specificity of over 90% in patients with sCJD [106] and PMCA with an almost 100% specificity and sensitivity to diagnose vCJD [163,164]. This evidence concerns the gene MDH1 and variant Creutzfeldt-Jakob disease.